- Home
- CAC vs PHAR Comparison
CAC vs PHAR Comparison
Compare CAC & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAC
- PHAR
- Stock Information
- Founded
- CAC 1875
- PHAR 1988
- Country
- CAC United States
- PHAR Netherlands
- Employees
- CAC N/A
- PHAR N/A
- Industry
- CAC Major Banks
- PHAR Biotechnology: Pharmaceutical Preparations
- Sector
- CAC Finance
- PHAR Health Care
- Exchange
- CAC Nasdaq
- PHAR Nasdaq
- Market Cap
- CAC 616.5M
- PHAR 627.5M
- IPO Year
- CAC 1997
- PHAR N/A
- Fundamental
- Price
- CAC $44.05
- PHAR $9.98
- Analyst Decision
- CAC Hold
- PHAR Strong Buy
- Analyst Count
- CAC 3
- PHAR 3
- Target Price
- CAC $46.67
- PHAR $27.00
- AVG Volume (30 Days)
- CAC 81.6K
- PHAR 6.0K
- Earning Date
- CAC 01-28-2025
- PHAR 03-13-2025
- Dividend Yield
- CAC 3.81%
- PHAR N/A
- EPS Growth
- CAC N/A
- PHAR N/A
- EPS
- CAC 3.20
- PHAR N/A
- Revenue
- CAC $168,756,000.00
- PHAR $285,745,000.00
- Revenue This Year
- CAC N/A
- PHAR $20.08
- Revenue Next Year
- CAC $30.91
- PHAR $9.22
- P/E Ratio
- CAC $13.76
- PHAR N/A
- Revenue Growth
- CAC N/A
- PHAR 30.64
- 52 Week Low
- CAC $28.62
- PHAR $6.65
- 52 Week High
- CAC $50.07
- PHAR $13.20
- Technical
- Relative Strength Index (RSI)
- CAC 53.88
- PHAR 56.13
- Support Level
- CAC $43.30
- PHAR $9.37
- Resistance Level
- CAC $44.78
- PHAR $10.15
- Average True Range (ATR)
- CAC 1.10
- PHAR 0.50
- MACD
- CAC 0.31
- PHAR -0.09
- Stochastic Oscillator
- CAC 83.45
- PHAR 57.53
About CAC Camden National Corporation
Camden National Corporation is a banking solutions provider in the United States. Its core business is providing commercial banking products to individuals and corporates. Its consumer and commercial banking services entail services such as loans and deposits, savings and online banking, treasury management solutions and non-profit products to consumer, institutional, municipal, non-profit and commercial customers. The company also offers investment management and fiduciary services.
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.